Asia Pacific Molecular Diagnostics Market Forecast to 2030 – Regional Analysis – by Disease Area (Oncology, Infectious Disease, Genetic Testing, Cardiac Diseases, Immune System Disorders, and Others), Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarrays, In-Situ Hybridization, and Others), Product and Services (Assays & Kits, Instruments, and Services & Software), and End User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, and Others)
The Asia Pacific molecular diagnostics market is expected to grow from US$ 3,478.48 million in 2022 to US$ 9,698.11 million by 2030. It is estimated to grow at a CAGR of 13.7% from 2022 to 2030.
Advancements in Molecular Diagnostics Technologies Fuels Asia Pacific Molecular Diagnostics Market
Molecular diagnostic techniques and platforms are being used in all areas of anatomic and clinical pathologies. DNA or RNA sequences that are associated with disease, including single nucleotide polymorphism, deletions, rearrangements, and insertions, can be detected in molecular diagnostic tests. Molecular diagnosis has undergone further improvements after the emergence of COVID-19. Conventionally, CT scans, hematological tests, and RT-PCR were in use for testing. As COVID-19 cases grew rapidly in 2020, the need for rapid, precise testing platforms surged to overcome the disadvantages of conventional testing. Computed tomography (CT), a cost-intensive procedure that may not be available in all hospitals, fails to detect viral infections and other diseases in asymptomatic patients. RT-PCR, which was widely used, was also time-consuming and expensive, and was unable to detect a low viral load during the early stages of infection. Consequently, researchers developed novel approaches to detect SARS-CoV-2, which were faster and more cost effective. Reverse transcription loop-mediated isothermal amplification (RT-LAMP), microarray-based detection, aptamer-based diagnosis, SHERLOCK, SHERLOCKv2, FET Biosensors, cell-based potentiometric diagnosis, and molecular imprinting technology are a few of the examples of novel molecular diagnostics techniques developed for COVID-19 diagnosis. In the last few years, FDA reports have indicated that advancements in molecular testing, antigen-dependent testing, and serological testing have been approved. Collaborative efforts by scientific communities in different countries to manage the COVID-19 pandemic and reduce the extent of mortality have benefited the overall molecular tools and diagnosis landscape, which is likely to create significant opportunities for the molecular diagnostics market in the future.
Asia Pacific Molecular Diagnostics Market Overview
Asia Pacific includes Malaysia, Thailand, India, Singapore, the Philippines, Vietnam, Indonesia, China, Japan, Australia, South Korea, and the Rest of Asia Pacific. Rising geriatric population, increasing cancer cases, growing technological advancements, and increasing number of startups, biotechnology, and biopharmaceutical companies are driving the molecular diagnostics market in this region. Moreover, the rise in research activities in the region and the presence of associations or organizations enhancing the quality of care in cancer contribute to the molecular diagnostics market growth.
Asia Pacific Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Molecular Diagnostics Market Segmentation
The Asia Pacific molecular diagnostics market is segmented into disease area, technology, product and services, end user, and country.
Based on disease area, the Asia Pacific molecular diagnostics market is segmented into infectious disease, oncology, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment registered the largest Asia Pacific molecular diagnostics market share in 2022.
Based on technology, the Asia Pacific molecular diagnostics market is segmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS), DNA microarrays, and others. The polymerase chain reaction (PCR) segment registered the largest Asia Pacific molecular diagnostics market share in 2022. The polymerase chain reaction (PCR) is further sub segmented into RT-PCR, qPCR, multiplex PCR, and others.
Based on product and services, the Asia Pacific molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment registered the largest Asia Pacific molecular diagnostics market share in 2022.
Based on end users, the Asia Pacific molecular diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, research and academic institutes, and others. The diagnostic laboratories segment held the largest Asia Pacific molecular diagnostics market share in 2022.
Based on country, the Asia Pacific molecular diagnostics market has been categorized into India, Singapore, Malaysia, Philippines, Thailand, Indonesia, Vietnam, China, Japan, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific molecular diagnostics market in 2022.
Abbott Laboratories, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, bioMerieux SA, Illumina Inc, Danaher, Siemens Healthineers AG, Novartis AG, and TBG Diagnostics Limited are some of the leading companies operating in the Asia Pacific molecular diagnostics market.
Advancements in Molecular Diagnostics Technologies Fuels Asia Pacific Molecular Diagnostics Market
Molecular diagnostic techniques and platforms are being used in all areas of anatomic and clinical pathologies. DNA or RNA sequences that are associated with disease, including single nucleotide polymorphism, deletions, rearrangements, and insertions, can be detected in molecular diagnostic tests. Molecular diagnosis has undergone further improvements after the emergence of COVID-19. Conventionally, CT scans, hematological tests, and RT-PCR were in use for testing. As COVID-19 cases grew rapidly in 2020, the need for rapid, precise testing platforms surged to overcome the disadvantages of conventional testing. Computed tomography (CT), a cost-intensive procedure that may not be available in all hospitals, fails to detect viral infections and other diseases in asymptomatic patients. RT-PCR, which was widely used, was also time-consuming and expensive, and was unable to detect a low viral load during the early stages of infection. Consequently, researchers developed novel approaches to detect SARS-CoV-2, which were faster and more cost effective. Reverse transcription loop-mediated isothermal amplification (RT-LAMP), microarray-based detection, aptamer-based diagnosis, SHERLOCK, SHERLOCKv2, FET Biosensors, cell-based potentiometric diagnosis, and molecular imprinting technology are a few of the examples of novel molecular diagnostics techniques developed for COVID-19 diagnosis. In the last few years, FDA reports have indicated that advancements in molecular testing, antigen-dependent testing, and serological testing have been approved. Collaborative efforts by scientific communities in different countries to manage the COVID-19 pandemic and reduce the extent of mortality have benefited the overall molecular tools and diagnosis landscape, which is likely to create significant opportunities for the molecular diagnostics market in the future.
Asia Pacific Molecular Diagnostics Market Overview
Asia Pacific includes Malaysia, Thailand, India, Singapore, the Philippines, Vietnam, Indonesia, China, Japan, Australia, South Korea, and the Rest of Asia Pacific. Rising geriatric population, increasing cancer cases, growing technological advancements, and increasing number of startups, biotechnology, and biopharmaceutical companies are driving the molecular diagnostics market in this region. Moreover, the rise in research activities in the region and the presence of associations or organizations enhancing the quality of care in cancer contribute to the molecular diagnostics market growth.
Asia Pacific Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Molecular Diagnostics Market Segmentation
The Asia Pacific molecular diagnostics market is segmented into disease area, technology, product and services, end user, and country.
Based on disease area, the Asia Pacific molecular diagnostics market is segmented into infectious disease, oncology, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment registered the largest Asia Pacific molecular diagnostics market share in 2022.
Based on technology, the Asia Pacific molecular diagnostics market is segmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS), DNA microarrays, and others. The polymerase chain reaction (PCR) segment registered the largest Asia Pacific molecular diagnostics market share in 2022. The polymerase chain reaction (PCR) is further sub segmented into RT-PCR, qPCR, multiplex PCR, and others.
Based on product and services, the Asia Pacific molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment registered the largest Asia Pacific molecular diagnostics market share in 2022.
Based on end users, the Asia Pacific molecular diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, research and academic institutes, and others. The diagnostic laboratories segment held the largest Asia Pacific molecular diagnostics market share in 2022.
Based on country, the Asia Pacific molecular diagnostics market has been categorized into India, Singapore, Malaysia, Philippines, Thailand, Indonesia, Vietnam, China, Japan, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific molecular diagnostics market in 2022.
Abbott Laboratories, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, bioMerieux SA, Illumina Inc, Danaher, Siemens Healthineers AG, Novartis AG, and TBG Diagnostics Limited are some of the leading companies operating in the Asia Pacific molecular diagnostics market.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. ASIA PACIFIC MOLECULAR DIAGNOSTICS MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific PEST Analysis
5. ASIA PACIFIC MOLECULAR DIAGNOSTICS MARKET - KEY INDUSTRY DYNAMICS
5.1 Key Market Drivers:
5.1.1 Development of New Products and Increase in Demand for Point-of-Care Testing
5.1.2 Surging Prevalence of Associated Diseases
5.2 Market Restraints
5.2.1 Limitations Associated with Molecular Testing
5.3 Market Opportunities
5.3.1 Advancements in Molecular Diagnostics Technologies
5.4 Future Trends
5.4.1 Molecular Diagnostics in Personalized Medicine
5.5 Impact Analysis:
6. MOLECULAR DIAGNOSTICS MARKET - ASIA PACIFIC MARKET ANALYSIS
6.1 Asia Pacific Molecular Diagnostics Market Revenue (US$ Mn), 2022 – 2030
7. ASIA PACIFIC MOLECULAR DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY DISEASE AREA
7.1 Overview
7.2 Asia Pacific Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
7.3 Oncology
7.3.1 Overview
7.3.2 Oncology: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Infectious Disease
7.4.1 Overview
7.4.2 Infectious Disease: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Genetic Testing
7.5.1 Overview
7.5.2 Genetic Testing: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Cardiac Diseases
7.6.1 Overview
7.6.2 Cardiac Diseases: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Immune System Disorders
7.7.1 Overview
7.7.2 Immune System Disorders: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8. ASIA PACIFIC MOLECULAR DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY TECHNOLOGY
8.1 Overview
8.2 Asia Pacific Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Polymerase Chain Reaction
8.3.1 Overview
8.3.2 PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 RT-PCR
8.3.2.1.1 Overview
8.3.3 RT-PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.3.1 qPCR
8.3.3.1.1 Overview
8.3.4 PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.4.1 Multiplex PCR
8.3.4.1.1 Overview
8.3.5 Multiplex PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.5.1 Others
8.3.5.1.1 Overview
8.3.6 Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.4.1 Overview
8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 DNA Sequencing and Next-Generation Sequencing (NGS)
8.5.1 Overview
8.5.2 DNA Sequencing and Next-Generation Sequencing (NGS): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.6 DNA Microarrays
8.6.1 Overview
8.6.2 DNA Microarrays: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.7 In-Situ Hybridization (ISH)
8.7.1 Overview
8.7.2 In-Situ Hybridization (ISH): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. ASIA PACIFIC MOLECULAR DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY PRODUCT AND SERVICES
9.1 Overview
9.2 Asia Pacific Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
9.3 Assays and Kits
9.3.1 Overview
9.3.2 Assays and Kits: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Instruments
9.4.1 Overview
9.4.2 Instruments: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Services and Software
9.5.1 Overview
9.5.2 Services and Software: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. ASIA PACIFIC MOLECULAR DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY END USER
10.1 Overview
10.2 Asia Pacific Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Diagnostics Laboratories
10.4.1 Overview
10.4.2 Diagnostics Laboratories: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Research and Academic Institutes
10.5.1 Overview
10.5.2 Research and Academic Institutes: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11. ASIA PACIFIC MOLECULAR DIAGNOSTICS MARKET - COUNTRY ANALYSIS
11.1 Asia Pacific Molecular Diagnostics Market, Revenue and Forecast to 2030
11.1.1 Overview
11.1.1.1 Asia Pacific Molecular Diagnostics Market by Country
11.1.2 China
11.1.2.1 Overview
11.1.3 China: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.4 China: Molecular Diagnostics Market, by Disease Area
11.1.5 China: Molecular Diagnostics Market, by Technology
11.1.5.1 China: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.6 China:Molecular Diagnostics Market, by Product and Services
11.1.7 China: Molecular Diagnostics Market, by End User
11.1.8 Japan
11.1.8.1 Overview
11.1.9 Japan: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.10 Japan: Molecular Diagnostics Market, by Disease Area
11.1.11 Japan: Molecular Diagnostics Market, by Technology
11.1.11.1 Japan: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.12 Japan: Molecular Diagnostics Market, by Product and Services
11.1.13 Japan: Molecular Diagnostics Market, by End User
11.1.14 India
11.1.14.1 Overview
11.1.15 India: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.16 India: Molecular Diagnostics Market, by Disease Area
11.1.17 India: Molecular Diagnostics Market, by Technology
11.1.17.1 India: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.18 India: Molecular Diagnostics Market, by Product and Services
11.1.19 India: Molecular Diagnostics Market, by End User
11.1.20 Australia
11.1.20.1 Overview
11.1.21 Australia: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.22 Australia: Molecular Diagnostics Market, by Disease Area
11.1.23 Australia: Molecular Diagnostics Market, by Technology
11.1.23.1 Australia: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.24 Australia: Molecular Diagnostics Market, by Product and Services
11.1.25 Australia: Molecular Diagnostics Market, by End User
11.1.26 South Korea
11.1.26.1 Overview
11.1.27 South Korea: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.28 South Korea: Molecular Diagnostics Market, by Disease Area
11.1.29 South Korea: Molecular Diagnostics Market, by Technology
11.1.29.1 South Korea: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.30 South Korea: Molecular Diagnostics Market, by Product and Services
11.1.31 South Korea: Molecular Diagnostics Market, by End User
11.1.32 Singapore
11.1.32.1 Overview
11.1.33 Singapore: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.34 Singapore: Molecular Diagnostics Market, by Disease Area
11.1.35 Singapore: Molecular Diagnostics Market, by Technology
11.1.35.1 Singapore: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.36 Singapore: Molecular Diagnostics Market, by Product and Services
11.1.37 Singapore: Molecular Diagnostics Market, by End User
11.1.38 Malaysia
11.1.38.1 Overview
11.1.39 Malaysia: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.40 Malaysia: Molecular Diagnostics Market, by Disease Area
11.1.41 Malaysia: Molecular Diagnostics Market, by Technology
11.1.41.1 Malaysia: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.42 Malaysia: Molecular Diagnostics Market, by Product and Services
11.1.43 Malaysia: Molecular Diagnostics Market, by End User
11.1.44 Philippines
11.1.44.1 Overview
11.1.45 Philippines: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.46 Philippines: Molecular Diagnostics Market, by Disease Area
11.1.47 Philippines: Molecular Diagnostics Market, by Technology
11.1.47.1 Philippines: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.48 Philippines: Molecular Diagnostics Market, by Product and Services
11.1.49 Philippines: Molecular Diagnostics Market, by End User
11.1.50 Thailand
11.1.50.1 Overview
11.1.51 Thailand: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.52 Thailand: Molecular Diagnostics Market, by Disease Area
11.1.53 Thailand: Molecular Diagnostics Market, by Technology
11.1.53.1 Thailand: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.54 Thailand: Molecular Diagnostics Market, by Product and Services
11.1.55 Thailand: Molecular Diagnostics Market, by End User
11.1.56 Indonesia
11.1.56.1 Overview
11.1.57 Indonesia: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.58 Indonesia: Molecular Diagnostics Market, by Disease Area
11.1.59 Indonesia: Molecular Diagnostics Market, by Technology
11.1.59.1 Indonesia: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.60 Indonesia: Molecular Diagnostics Market, by Product and Services
11.1.61 Indonesia: Molecular Diagnostics Market, by End User
11.1.62 Vietnam
11.1.62.1 Overview
11.1.63 Vietnam: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.64 Vietnam: Molecular Diagnostics Market, by Disease Area
11.1.65 Vietnam: Molecular Diagnostics Market, by Technology
11.1.65.1 Vietnam: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.66 Vietnam: Molecular Diagnostics Market, by Product and Services
11.1.67 Vietnam: Molecular Diagnostics Market, by End User
11.1.68 Rest of Asia Pacific
11.1.68.1 Overview
11.1.69 Rest of Asia Pacific: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.70 Rest of Asia Pacific: Molecular Diagnostics Market, by Disease Area
11.1.71 Rest of Asia Pacific: Molecular Diagnostics Market, by Technology
11.1.71.1 Rest of Asia Pacific: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.72 Rest of Asia Pacific: Molecular Diagnostics Market, by Product and Services
11.1.73 Rest of Asia Pacific: Molecular Diagnostics Market, by End User
12. ASIA PACIFIC MOLECULAR DIAGNOSTICS MARKET INDUSTRY LANDSCAPE
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. ASIA PACIFIC MOLECULAR DIAGNOSTICS MARKET, KEY COMPANY PROFILES
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Agilent Technologies Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Thermo Fisher Scientific Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 F. Hoffmann-La Roche Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Qiagen NV
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 bioMerieux SA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Illumina Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Danaher
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Siemens Healthineers AG
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Novartis AG
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 TBG Diagnostics Limited
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
14. APPENDIX
14.1 About Us
14.2 Glossary of Terms
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. ASIA PACIFIC MOLECULAR DIAGNOSTICS MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific PEST Analysis
5. ASIA PACIFIC MOLECULAR DIAGNOSTICS MARKET - KEY INDUSTRY DYNAMICS
5.1 Key Market Drivers:
5.1.1 Development of New Products and Increase in Demand for Point-of-Care Testing
5.1.2 Surging Prevalence of Associated Diseases
5.2 Market Restraints
5.2.1 Limitations Associated with Molecular Testing
5.3 Market Opportunities
5.3.1 Advancements in Molecular Diagnostics Technologies
5.4 Future Trends
5.4.1 Molecular Diagnostics in Personalized Medicine
5.5 Impact Analysis:
6. MOLECULAR DIAGNOSTICS MARKET - ASIA PACIFIC MARKET ANALYSIS
6.1 Asia Pacific Molecular Diagnostics Market Revenue (US$ Mn), 2022 – 2030
7. ASIA PACIFIC MOLECULAR DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY DISEASE AREA
7.1 Overview
7.2 Asia Pacific Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
7.3 Oncology
7.3.1 Overview
7.3.2 Oncology: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Infectious Disease
7.4.1 Overview
7.4.2 Infectious Disease: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Genetic Testing
7.5.1 Overview
7.5.2 Genetic Testing: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Cardiac Diseases
7.6.1 Overview
7.6.2 Cardiac Diseases: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Immune System Disorders
7.7.1 Overview
7.7.2 Immune System Disorders: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8. ASIA PACIFIC MOLECULAR DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY TECHNOLOGY
8.1 Overview
8.2 Asia Pacific Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Polymerase Chain Reaction
8.3.1 Overview
8.3.2 PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 RT-PCR
8.3.2.1.1 Overview
8.3.3 RT-PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.3.1 qPCR
8.3.3.1.1 Overview
8.3.4 PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.4.1 Multiplex PCR
8.3.4.1.1 Overview
8.3.5 Multiplex PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.5.1 Others
8.3.5.1.1 Overview
8.3.6 Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.4.1 Overview
8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 DNA Sequencing and Next-Generation Sequencing (NGS)
8.5.1 Overview
8.5.2 DNA Sequencing and Next-Generation Sequencing (NGS): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.6 DNA Microarrays
8.6.1 Overview
8.6.2 DNA Microarrays: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.7 In-Situ Hybridization (ISH)
8.7.1 Overview
8.7.2 In-Situ Hybridization (ISH): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. ASIA PACIFIC MOLECULAR DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY PRODUCT AND SERVICES
9.1 Overview
9.2 Asia Pacific Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
9.3 Assays and Kits
9.3.1 Overview
9.3.2 Assays and Kits: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Instruments
9.4.1 Overview
9.4.2 Instruments: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Services and Software
9.5.1 Overview
9.5.2 Services and Software: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. ASIA PACIFIC MOLECULAR DIAGNOSTICS MARKET – REVENUE AND FORECAST TO 2030 – BY END USER
10.1 Overview
10.2 Asia Pacific Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Diagnostics Laboratories
10.4.1 Overview
10.4.2 Diagnostics Laboratories: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Research and Academic Institutes
10.5.1 Overview
10.5.2 Research and Academic Institutes: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11. ASIA PACIFIC MOLECULAR DIAGNOSTICS MARKET - COUNTRY ANALYSIS
11.1 Asia Pacific Molecular Diagnostics Market, Revenue and Forecast to 2030
11.1.1 Overview
11.1.1.1 Asia Pacific Molecular Diagnostics Market by Country
11.1.2 China
11.1.2.1 Overview
11.1.3 China: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.4 China: Molecular Diagnostics Market, by Disease Area
11.1.5 China: Molecular Diagnostics Market, by Technology
11.1.5.1 China: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.6 China:Molecular Diagnostics Market, by Product and Services
11.1.7 China: Molecular Diagnostics Market, by End User
11.1.8 Japan
11.1.8.1 Overview
11.1.9 Japan: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.10 Japan: Molecular Diagnostics Market, by Disease Area
11.1.11 Japan: Molecular Diagnostics Market, by Technology
11.1.11.1 Japan: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.12 Japan: Molecular Diagnostics Market, by Product and Services
11.1.13 Japan: Molecular Diagnostics Market, by End User
11.1.14 India
11.1.14.1 Overview
11.1.15 India: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.16 India: Molecular Diagnostics Market, by Disease Area
11.1.17 India: Molecular Diagnostics Market, by Technology
11.1.17.1 India: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.18 India: Molecular Diagnostics Market, by Product and Services
11.1.19 India: Molecular Diagnostics Market, by End User
11.1.20 Australia
11.1.20.1 Overview
11.1.21 Australia: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.22 Australia: Molecular Diagnostics Market, by Disease Area
11.1.23 Australia: Molecular Diagnostics Market, by Technology
11.1.23.1 Australia: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.24 Australia: Molecular Diagnostics Market, by Product and Services
11.1.25 Australia: Molecular Diagnostics Market, by End User
11.1.26 South Korea
11.1.26.1 Overview
11.1.27 South Korea: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.28 South Korea: Molecular Diagnostics Market, by Disease Area
11.1.29 South Korea: Molecular Diagnostics Market, by Technology
11.1.29.1 South Korea: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.30 South Korea: Molecular Diagnostics Market, by Product and Services
11.1.31 South Korea: Molecular Diagnostics Market, by End User
11.1.32 Singapore
11.1.32.1 Overview
11.1.33 Singapore: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.34 Singapore: Molecular Diagnostics Market, by Disease Area
11.1.35 Singapore: Molecular Diagnostics Market, by Technology
11.1.35.1 Singapore: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.36 Singapore: Molecular Diagnostics Market, by Product and Services
11.1.37 Singapore: Molecular Diagnostics Market, by End User
11.1.38 Malaysia
11.1.38.1 Overview
11.1.39 Malaysia: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.40 Malaysia: Molecular Diagnostics Market, by Disease Area
11.1.41 Malaysia: Molecular Diagnostics Market, by Technology
11.1.41.1 Malaysia: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.42 Malaysia: Molecular Diagnostics Market, by Product and Services
11.1.43 Malaysia: Molecular Diagnostics Market, by End User
11.1.44 Philippines
11.1.44.1 Overview
11.1.45 Philippines: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.46 Philippines: Molecular Diagnostics Market, by Disease Area
11.1.47 Philippines: Molecular Diagnostics Market, by Technology
11.1.47.1 Philippines: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.48 Philippines: Molecular Diagnostics Market, by Product and Services
11.1.49 Philippines: Molecular Diagnostics Market, by End User
11.1.50 Thailand
11.1.50.1 Overview
11.1.51 Thailand: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.52 Thailand: Molecular Diagnostics Market, by Disease Area
11.1.53 Thailand: Molecular Diagnostics Market, by Technology
11.1.53.1 Thailand: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.54 Thailand: Molecular Diagnostics Market, by Product and Services
11.1.55 Thailand: Molecular Diagnostics Market, by End User
11.1.56 Indonesia
11.1.56.1 Overview
11.1.57 Indonesia: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.58 Indonesia: Molecular Diagnostics Market, by Disease Area
11.1.59 Indonesia: Molecular Diagnostics Market, by Technology
11.1.59.1 Indonesia: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.60 Indonesia: Molecular Diagnostics Market, by Product and Services
11.1.61 Indonesia: Molecular Diagnostics Market, by End User
11.1.62 Vietnam
11.1.62.1 Overview
11.1.63 Vietnam: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.64 Vietnam: Molecular Diagnostics Market, by Disease Area
11.1.65 Vietnam: Molecular Diagnostics Market, by Technology
11.1.65.1 Vietnam: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.66 Vietnam: Molecular Diagnostics Market, by Product and Services
11.1.67 Vietnam: Molecular Diagnostics Market, by End User
11.1.68 Rest of Asia Pacific
11.1.68.1 Overview
11.1.69 Rest of Asia Pacific: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.70 Rest of Asia Pacific: Molecular Diagnostics Market, by Disease Area
11.1.71 Rest of Asia Pacific: Molecular Diagnostics Market, by Technology
11.1.71.1 Rest of Asia Pacific: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.72 Rest of Asia Pacific: Molecular Diagnostics Market, by Product and Services
11.1.73 Rest of Asia Pacific: Molecular Diagnostics Market, by End User
12. ASIA PACIFIC MOLECULAR DIAGNOSTICS MARKET INDUSTRY LANDSCAPE
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. ASIA PACIFIC MOLECULAR DIAGNOSTICS MARKET, KEY COMPANY PROFILES
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Agilent Technologies Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Thermo Fisher Scientific Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 F. Hoffmann-La Roche Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Qiagen NV
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 bioMerieux SA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Illumina Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Danaher
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Siemens Healthineers AG
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Novartis AG
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 TBG Diagnostics Limited
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
14. APPENDIX
14.1 About Us
14.2 Glossary of Terms
